Hubungan ekspresi pulasan imunohistokimia Protein Gene Product (PGP9.5) dengan derajat histopatologi kanker ovarium tipe adenokarsinoma serosum dan tipe adenokarsinoma musinosum
53
REFERENSI
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
Cotran RS, Kumar V, Collins T. Robbins Pathologic, Basis of Disease.
Seventh ed.W.B Saunders Company.2005:1093-1100.
Desen W. Buku Ajar Onkologi Klinik, Edisi II. Fakultas Kedokteran
Universitas Indonesia. 2008:50-158.
Shih IM, Kurman RJ. Ovarian serous Carcinogenesis Model : A Proposed
Model. Molecular Pathology of Gynecologyc Cancer. Humana Press Inc.
2007: 17-26.
Lee KR, Tavassoli FA, Prat J, Dietel M, Gersell DJ, Karseladze Al, et al.
The WHO Classification of Tumours; Pathology and Genetics of Tumours
of Breast and Female Genital Organs. France: IARC Press. 2003:140-143.
Alferraly,T.Ibnu, Intan,T.Kemala, Waruwu,D. Hubungan Usia Dengan
Gambaran Histopatologi Kanker Ovarium di Kota Medan Tahun 2010-2011.
Medan. Fakultas Kedokteran Universitas Sumatera Utara. Available :
http://repository.usu.ac.id/handle/12345678/37092.
Sihombing M, Sirait AM. Angka Ketahanan Hidup Penderita Kanker
Ovarium di RS. Cipto Mangunkusumo Jakarta. Majalah kedokteran
Indonesia. Volue 57: Nomor: 10: 2007.
Shih IM, Kurman RJ. Ovarian Tumoregenesis: A Proposed Model Based On
Morphological and Molecular Genetic Analysis. American Journal of
Pathology. Volume 164: Number 5: 2004.
Brait M, Maldonado Leonel, et al. Association of Promoter Methylation of
VGF and PGP9.5 with Ovarian Cancer Progression. Volume 8: Issue 9:2013.
Chandrasoma P, Taylor CR. Concise Pathology. Third Ed. McGrow Hill.
2001:788-789
Leung PCK, Eli Y. The ovary. Second edition. Elsevier Academic Press.
2004:579-586, 591-602.
Kierszenbaum AL MD. Histology and Cell Biology: an Introduction to
Pathology. Second edition: Elseiver Inc: 2007.
Cannistra SA. Cancer of The Ovary. The New England Journal of Medicine.
Volume 351: Number 24: 2004.
Odicino F. Pecorelli S, Zigliani L, Creasman WT. History of the FIGO
cancer staging system. International Journal of Gynecology and Obstetrics.
Volume 101: 2008:205-210.
Raphael R, Strayer D.S. Rubin's Pathology: Clinicopathologic Foundation of
Medicine. Lippincott Williams & Wilkins. Phiadephia. 2008:818-823.
Rosai J. Rosai and Aeckerman's Surgical Pathology: Surface Epithelial
Tumor. Mosby. Philadelphia. Volume 2: 2004: p 1562-1569.
Kaku T. Ogawa S. Ohishi Y. Histological classification of ovarian cancer.
The Clinical Electron Microssopy Society of japan. 2003:36:9-17.
Bartlett JMS. Ovarian Cancer, Methods and Protocolls. Humana Press.
Volume 39: 2007:1-70.
Dabbs D.J Diagnostic Immunohistochemistry : Ovarian cancer. Churcill
Livingstone Elseiver. Philadelphia. Second Ed: 2006:667-669.
Nucci Marisa R. Oliva Esther. Gynecologic Pathology; Surface Epithelial
Stromal Tumors of the Ovary. Elseiver Livingstone. 2009:393-445.
54
20. Soslow Robert A. Riview; Histologic Subtypes of Ovarian Carcinoma: An
Overview. International Journal of Gynecological Pathology. Lippincott
Williams & Wilkins. 2008: 27:161-174.
21. Schorge. Schaffer et al. Williams Gynecology, Epithelial Ovarian Cancer.
McGraw-Hill Compnies. 2008.
22. Campbell LK, Thomas JR. Lamps LW, Smoller BR, Folpe AL. Protein Gene
Product 9.5 (PGP9.5) is not a specific marker of neural and nerve sheath
tumors : An Immunohistochemical study of 95 mesenchymal neoplasm.
Modern Pathology. 2003: 16:10:963-69.
23. Mizukami et al., PGP9.5 Methylation as A Marker for Metastatic Colorectal
Cancer; Anticancer Research. 2008: 28:2697-2700.
24. Tokumaru Y, Yamashita K, kim MS et al. The role of PGP9.5 as a tumor
suppressor gene in human cancer. Wiley-Liss Inc. International J.Cancer:
123: 2008: 753-759.
REFERENSI
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
Cotran RS, Kumar V, Collins T. Robbins Pathologic, Basis of Disease.
Seventh ed.W.B Saunders Company.2005:1093-1100.
Desen W. Buku Ajar Onkologi Klinik, Edisi II. Fakultas Kedokteran
Universitas Indonesia. 2008:50-158.
Shih IM, Kurman RJ. Ovarian serous Carcinogenesis Model : A Proposed
Model. Molecular Pathology of Gynecologyc Cancer. Humana Press Inc.
2007: 17-26.
Lee KR, Tavassoli FA, Prat J, Dietel M, Gersell DJ, Karseladze Al, et al.
The WHO Classification of Tumours; Pathology and Genetics of Tumours
of Breast and Female Genital Organs. France: IARC Press. 2003:140-143.
Alferraly,T.Ibnu, Intan,T.Kemala, Waruwu,D. Hubungan Usia Dengan
Gambaran Histopatologi Kanker Ovarium di Kota Medan Tahun 2010-2011.
Medan. Fakultas Kedokteran Universitas Sumatera Utara. Available :
http://repository.usu.ac.id/handle/12345678/37092.
Sihombing M, Sirait AM. Angka Ketahanan Hidup Penderita Kanker
Ovarium di RS. Cipto Mangunkusumo Jakarta. Majalah kedokteran
Indonesia. Volue 57: Nomor: 10: 2007.
Shih IM, Kurman RJ. Ovarian Tumoregenesis: A Proposed Model Based On
Morphological and Molecular Genetic Analysis. American Journal of
Pathology. Volume 164: Number 5: 2004.
Brait M, Maldonado Leonel, et al. Association of Promoter Methylation of
VGF and PGP9.5 with Ovarian Cancer Progression. Volume 8: Issue 9:2013.
Chandrasoma P, Taylor CR. Concise Pathology. Third Ed. McGrow Hill.
2001:788-789
Leung PCK, Eli Y. The ovary. Second edition. Elsevier Academic Press.
2004:579-586, 591-602.
Kierszenbaum AL MD. Histology and Cell Biology: an Introduction to
Pathology. Second edition: Elseiver Inc: 2007.
Cannistra SA. Cancer of The Ovary. The New England Journal of Medicine.
Volume 351: Number 24: 2004.
Odicino F. Pecorelli S, Zigliani L, Creasman WT. History of the FIGO
cancer staging system. International Journal of Gynecology and Obstetrics.
Volume 101: 2008:205-210.
Raphael R, Strayer D.S. Rubin's Pathology: Clinicopathologic Foundation of
Medicine. Lippincott Williams & Wilkins. Phiadephia. 2008:818-823.
Rosai J. Rosai and Aeckerman's Surgical Pathology: Surface Epithelial
Tumor. Mosby. Philadelphia. Volume 2: 2004: p 1562-1569.
Kaku T. Ogawa S. Ohishi Y. Histological classification of ovarian cancer.
The Clinical Electron Microssopy Society of japan. 2003:36:9-17.
Bartlett JMS. Ovarian Cancer, Methods and Protocolls. Humana Press.
Volume 39: 2007:1-70.
Dabbs D.J Diagnostic Immunohistochemistry : Ovarian cancer. Churcill
Livingstone Elseiver. Philadelphia. Second Ed: 2006:667-669.
Nucci Marisa R. Oliva Esther. Gynecologic Pathology; Surface Epithelial
Stromal Tumors of the Ovary. Elseiver Livingstone. 2009:393-445.
54
20. Soslow Robert A. Riview; Histologic Subtypes of Ovarian Carcinoma: An
Overview. International Journal of Gynecological Pathology. Lippincott
Williams & Wilkins. 2008: 27:161-174.
21. Schorge. Schaffer et al. Williams Gynecology, Epithelial Ovarian Cancer.
McGraw-Hill Compnies. 2008.
22. Campbell LK, Thomas JR. Lamps LW, Smoller BR, Folpe AL. Protein Gene
Product 9.5 (PGP9.5) is not a specific marker of neural and nerve sheath
tumors : An Immunohistochemical study of 95 mesenchymal neoplasm.
Modern Pathology. 2003: 16:10:963-69.
23. Mizukami et al., PGP9.5 Methylation as A Marker for Metastatic Colorectal
Cancer; Anticancer Research. 2008: 28:2697-2700.
24. Tokumaru Y, Yamashita K, kim MS et al. The role of PGP9.5 as a tumor
suppressor gene in human cancer. Wiley-Liss Inc. International J.Cancer:
123: 2008: 753-759.